A Study to Evaluate the Efficacy of a Hybrid Imaging and Measurement Tool for Breast Cancer Detection and Monitoring


About this study

The purpose of this research is to optimize and evaluate the efficacy of a hybrid imaging and quantitative viscoelasticity measurement tool for breast cancer detection and monitoring.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patient volunteers aged 18 years and older 
  • Without a history of mastectomy or implants 
  • Which are identified to have findings suspicious for breast cancer, or not suspicious, and may be referred to Radiology for clinical MRI and/or ultrasound, and may have had a baseline MRI, will be candidates for enrollment
  • Have biopsy proven breast cancer and are planning to be treated with neo-adjuvant chemotherapy and had their baseline MRI and/or ultrasound. VA/SDUV/CUSE will be performed after diagnostic biopsy in this group of patients

Exclusion Criteria:

  • Having any condition that does not allow proper use of our imaging devices 
  • History of mastectomy or implants



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Azra Alizad, M.D.

Open for enrollment

Contact information:

Patricia O'Neil

(507) 284-1375


More information


Publications are currently not available

Mayo Clinic Footer